Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression

Bibliographic Data

ID15524029
AuthorsTenghong Lian (Beijing Tian Tan Hospital), Teng-Hong Lian, Peng Guo (0000-0001-7858-4884, Capital Medical University), Lijun Zuo (0000-0001-6554-0815, Capital Medical University), Li-Jun Zuo, Yang Hu (0000-0003-2027-8491, Capital Medical University), Shuyang Yu (0000-0002-4686-3296, Capital Medical University), Shu-Yang Yu, Li Liu (0000-0002-5257-3391, Beijing Tian Tan Hospital), Zhao Jin (0000-0003-2547-4723, Beijing Tian Tan Hospital), Qiu-Jin Yu (Beijing Tian Tan Hospital), Ruidan Wang (0000-0002-1630-6691, Capital Medical University), Rui-Dan Wang, Lixia Li (0000-0002-0482-5275, Capital Medical University), Li-Xia Li, Ying‐shan Piao (Capital Medical University), Ying-Shan Piao, Wei Zhang (0000-0002-5458-9581, Capital Medical University, corresponding author)
Year2019
Volume9
Pages723-723
Publication date2019-01-18
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2018.00723
PMID30713507
OpenAlexW2909701676
LanguageEN
References cited61

Objective: To investigate the clinical features and neurochemical changes in Parkinson's disease with depression (PD-D). Methods: A total of 478 PD patients were divided into PD-D and PD patients without depression (PD-ND) groups according to the 24-item Hamilton Depression Rating Scale (HAMD) score. Demographic variables, motor and non-motor symptoms and activities of daily living were evaluated. The independent influencing factors of PD-D were investigated via binary logistic regression analysis. The levels of neurotransmitters in cerebrospinal fluid (CSF) were measured and their correlations with HAMD score were analyzed. Results: The proportion of PD-D was 59.0%, of which 76.95, 20.92, and 2.13% had mild, moderate, and severe depression, respectively. Anxiety/somatization was the most prevalent sub-factor of HAMD in PD-D. The scores of UPDRS III, postural instability/gait difficulty (PIGD) type and the scores of 14-item Hamilton Anxiety Scale (HAMA) and 14-item Chalder Fatigue Scale (FS) were independently associated with PD-D. The levels of dopamine (DA) and 5-hydroxytryptamine (5-HT) were all significantly reduced in PD-D group compared with those in PD-ND group. HAMD scores were negatively correlated with the DA levels in CSF. Conclusions : PD patients have a high proportion of depression, mainly of mild and moderate levels. The profile of depression in PD population is subtly different from that of the general population. Motor symptoms, PIGD type, anxiety and fatigue are the significant influencing factors of PD-D. Compared to 5-HT, DA may play a more important role in PD-D

Depression (economics · Disease · Neurochemical · Parkinson's disease · Psychiatry · Medicine · Neurological disorders and treatments · Neuroscience · Parkinson's Disease Mechanisms and Treatments · Psychology · Restless Legs Syndrome Research · Internal Medicine

  • Development of a fatigue scale

    Open Access•Trudie Chalder, G Berelowitz et al.•Journal of Psychosomatic Research•1993

  • The Assessment of Anxiety States by Rating

    Open Access•MAX HAMILTON•British Journal of Medical…•1959

Citation velocityhistorical
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae